Historical record - last NADAC effective date: 1/18/2023
This NDC is on FDA's drug shortage list (posted Jan 19, 2023)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
QUINAPRIL 40 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0960 per EA under NDC 65862062090. Its NADAC has been published 529 times since Nov 28, 2013.
FDA first approved this application on Apr 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862062090
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/18/2023
Active Ingredients
QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202725FDA Approved
4/29/2013
TE Code
AB
On Market Since
4/29/2013
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL 40 MG TABLET has been published 529 times since Nov 28, 2013, and over the history we have for it it has declined 40.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0960 per EA |
|---|---|
| All-time high | $0.1615 (Mar 12, 2014) |
| All-time low | $0.0960 (Jan 18, 2023) |
| Median price | $0.1240 |
| Average price | $0.1288 |
| Largest weekly change | -10.7% (Jan 18, 2023) |
| Weeks tracked | 529 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
-14.0%
All
-40.0%
Last surveyed Jan 10, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Quinapril Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUINAPRIL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL 40 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0960 per EA (NDC 65862062090), effective Jan 10, 2024.
How has the price of QUINAPRIL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUINAPRIL 40 MG TABLET has declined 40.0%. It has been tracked across 529 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUINAPRIL 40 MG TABLET?
Since Nov 28, 2013, the NADAC for QUINAPRIL 40 MG TABLET has ranged from a low of $0.0960 (Jan 18, 2023) to a high of $0.1615 (Mar 12, 2014), with a median of $0.1240 per EA.
Are there cheaper alternatives to QUINAPRIL 40 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of QUINAPRIL 40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUINAPRIL 40 MG TABLET?
QUINAPRIL 40 MG TABLET (NDC 65862062090) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Is QUINAPRIL 40 MG TABLET in shortage?
Yes — NDC 65862062090 is currently listed in FDA's drug shortage database (posted Jan 19, 2023). Reported reason: Discontinuation of the manufacture of the drug.